GLIPR2
Golgi-associated plant pathogenesis-related protein 1
Also known as: C9orf19, GAPR-1, GAPR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H4G4
- Gene
- GLIPR2
- Ensembl
- ENSG00000122694
- Chromosome
- 9
- Canonical length
- 154 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Microtubules
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables protein homodimerization activity. Involved in positive regulation of ERK1 and ERK2 cascade; positive regulation of epithelial cell migration; and positive regulation of epithelial to mesenchymal transition. Located in Golgi membrane. Biomarker of pancreatic ductal adenocarcinoma. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
154 residues, UniProt reviewed canonical sequence.
>Q9H4G4|GLIPR2
1 MGKSASKQFH NEVLKAHNEY RQKHGVPPLK LCKNLNREAQ QYSEALASTR ILKHSPESSR
61 GQCGENLAWA SYDQTGKEVA DRWYSEIKNY NFQQPGFTSG TGHFTAMVWK NTKKMGVGKA
121 SASDGSSFVV ARYFPAGNVV NEGFFEENVL PPKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLIPR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- colon: 70 nTPM
- bone marrow: 70 nTPM
- endometrium: 66 nTPM
- smooth muscle: 60 nTPM
- lung: 59 nTPM
- appendix: 50 nTPM
Single-cell type
- neutrophils: 576 nCPM
- breast lactating cells: 342 nCPM
- monocytes: 285 nCPM
- neutrophil progenitors: 211 nCPM
- cdc: 194 nCPM
- monocyte progenitors: 169 nCPM
Immune cell
- neutrophil: 660 nTPM
- eosinophil: 542 nTPM
- total PBMC: 414 nTPM
- classical monocyte: 362 nTPM
- basophil: 270 nTPM
- myeloid DC: 209 nTPM
Brain region
- thalamus: 35 nTPM
- white matter: 33 nTPM
- medulla oblongata: 29 nTPM
- spinal cord: 23 nTPM
- basal ganglia: 22 nTPM
- midbrain: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.59
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of epithelial cell migration
- positive regulation of epithelial to mesenchymal transition
- positive regulation of ERK1 and ERK2 cascade
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine-rich secretory protein-related
- CAP domain
- Allergen V5/Tpx-1-related, conserved site
- CAP superfamily
- Cysteine-rich secretory protein family
- Golgi-associated plant pathogenesis-related protein 1, SCP domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GLIPR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLIPR2 as an antibody target. Whether an autoantibody or antibody against GLIPR2 could matter depends on whether native GLIPR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLIPR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLIPR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...